Shopping Cart
- Remove All
Your shopping cart is currently empty
CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $446 | 6-8 weeks | |
| 25 mg | $1,430 | 6-8 weeks | |
| 50 mg | $1,860 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM). |
| Targets&IC50 | Gastrin/CCK-B:0.43 nM , Gastrin/CCK-A:1.82 μM |
| In vivo | CCK-B Receptor Antagonist 2 (0.1 μmol/kg; i.v.) inhibits pentagastrin-induced gastric acid secretion in anesthetized rats, with an ED50 of 8.3 nmol/kg. |
| Molecular Weight | 484.55 |
| Formula | C27H28N6O3 |
| Cas No. | 155412-88-7 |
| Relative Density. | 1.29 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (515.94 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.